Staying current with genetic testing updates is a growing challenge in modern oncology. In its April 2025 white paper, “Oncology Insights: The Speed and Scope of Genetic Updates,” digital health company My Gene Counsel highlights how innovative technology can bridge the widening gap in precision medicine.
Genetic testing adoption remains low—even among cancer patients who qualify—due to systemic workflow barriers and the overwhelming pace of medical change. Clinicians often lack the tools to stay updated or re-engage patients when guidelines shift.
My Gene Counsel’s solution? Living Lab Reports—automated, web-based genetic reports that provide continuous updates to both providers and patients. These reports ensure that critical changes in genetic guidelines, risk assessments, and medical management are instantly accessible and actionable.
In 2023 and 2024, My Gene Counsel issued hundreds of updates affecting over 90 hereditary cancer genes, delivering timely insights to support oncology care teams and health systems at scale.
By streamlining genetic information delivery, My Gene Counsel is making precision medicine more effective, equitable, and sustainable.
Download the white paper to learn how My Gene Counsel is setting a new standard in digital health and genetic testing support (here).
